Pharmaceutical Economics Series Part 2 “Jump Before You’re Cooked”—Is D2C a non-issue for Pharmaceuticals?

In Part 2 of the “Pharmaceutical Economics” publication “Jump Before You’re Cooked”, we explore the keyword “D2C (Direct to Consumer) Increase”, reviewing examples of the EC/D2C overseas as well as explain what it may mean for the domestic pharmaceutical industry.
Author: Shuhei Yamada (Manager)